News
DRTS
9.64
-2.43%
-0.24
Alpha Tau Medical Price Target Raised to $14.00/Share From $12.00 by Ladenburg Thalmann
Dow Jones · 1d ago
Alpha Tau Medical Is Maintained at Buy by Ladenburg Thalmann
Dow Jones · 1d ago
Ladenburg Thalmann Maintains Buy on Alpha Tau Medical, Raises Price Target to $14
Benzinga · 1d ago
Analysts Have Conflicting Sentiments on These Healthcare Companies: BioNTech SE (BNTX), Personalis (PSNL) and Alpha Tau Medical Ltd (DRTS)
TipRanks · 1d ago
Alpha Tau price target raised to $15 from $12 at H.C. Wainwright
TipRanks · 1d ago
Alpha Tau Medical Price Target Raised to $15.00/Share From $12.00 by HC Wainwright & Co.
Dow Jones · 1d ago
Alpha Tau Medical Is Maintained at Buy by HC Wainwright & Co.
Dow Jones · 1d ago
HC Wainwright & Co. Maintains Buy on Alpha Tau Medical, Raises Price Target to $15
Benzinga · 1d ago
12 Health Care Stocks Moving In Monday's Intraday Session
Benzinga · 2d ago
Alpha Tau Medical Stock Surges As Interim Brain Tumor Trial Data Sparks Rally
Benzinga · 2d ago
Alpha Tau Wiped Out Visible Tumors in Two of Three Brain Cancer Patients in Its First U.S. Trial
TipRanks · 2d ago
Alpha Tau Medical Shares Interim U.S. Glioblastoma Trial Data for Alpha DaRT
TipRanks · 2d ago
Alpha Tau announces interim data from REGAIN trial
TipRanks · 2d ago
Alpha Tau REGAINs Momentum On Brain Cancer Study Data
NASDAQ · 2d ago
12 Health Care Stocks Moving In Monday's Pre-Market Session
Benzinga · 2d ago
Alpha Tau Posts Strong Interim REGAIN Data in U.S. Recurrent Glioblastoma Trial
TipRanks · 2d ago
Alpha Tau Alpha DaRT glioblastoma trial shows 67% complete response in interim data
PUBT · 2d ago
ALPHA TAU ANNOUNCES GROUNDBREAKING INTERIM RESULTS FROM ITS U.S. ALPHA DART® RECURRENT GLIOBLASTOMA TRIAL, WITH 100% LOCAL DISEASE CONTROL, 67% COMPLETE RESPONSE RATE, AND FAVORABLE SAFETY PROFILE OBSERVED - CONFERENCE CALL SCHEDULED FOR 8:30AM ET
Reuters · 2d ago
Weekly Report: what happened at DRTS last week (0504-0508)?
Weekly Report · 2d ago
Alpha Tau completes enrollment in ReSTART trial
TipRanks · 5d ago
More
Webull provides a variety of real-time DRTS stock news. You can receive the latest news about Alpha Tau Medical Ltd through multiple platforms. This information may help you make smarter investment decisions.
About DRTS
Alpha Tau Medical Ltd is an Israel-based medical technology company that focuses on research, development and commercialization of Alpha DaRT Diffusing Alpha-emitters Radiation Therapy (Alpha DaRT) for the treatment of solid cancer. Company's technology relies on the diffusion of atoms that emit alpha particles within the tumor tissue, and enables alpha radiation to reach the the entire tumor. Precise amounts of radioactive radium-224 affixed that emit short-range alpha radiation enables to damages and kills cancer cells within a short period of time. The Company has one subsidiary Healthcare Capital Corp.